Apollo Quattro (APQ-10M)
Weero Co., Ltd. · Decision date Mar 13, 2026
What did the FDA decide?
FDA records K253261 as a 510(k) premarket notification, with a decision dated Mar 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 13, 2026
Regulatory record facts
- Identifier
- K253261
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Weero Co., Ltd.
- Product code
- PBX
- Decision code
- SESE
- Decision date
- Mar 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Massager, Vacuum, Radio Frequency Induced Heat.
- Applicant
- Weero Co., Ltd.
- Product code
- PBX
- FDA device class
- 2
FDA decision timeline
K253261 received
Application receipt date recorded by FDA.
K253261 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PBX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Dongdixin Technology Co., Ltd. | 510(k) clearance | Oct 13, 2026 | FDA | |
| Bh Group Us, LLC | 510(k) clearance | Sep 22, 2026 | FDA | |
| Capenergy Medical S.L. | 510(k) clearance | Jul 10, 2026 | FDA | |
SPECCHIOK260647 | El.En S.P.A. | 510(k) clearance | Apr 2, 2026 | FDA |
NeoSculpt PlusK252888 | S&M Medical Co., Ltd. | 510(k) clearance | Mar 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Weero Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suwon
Sources and methodology
- Original FDA record: K253261
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



